-density lipoprotein (LDL) is a carrier of the cholesterol found in human plasma. Cells utilize cholesterol for membrane synthesis by taking up LDL via receptor-mediated endocytosis. In the present study, interactions of LDL with human malignant glioma cell lines (U-251MG and KMG-5) were investigated biochemically and morphologically. The LDL, labeled with the fluorescent dyes 1,1 '-dioctadecyl-3,3,Y,Y-tetramethylindocarbocyanine (DiI) and fluorescein isothiocyanate (FITC), was internalized by both cell processes and cell bodies. Reductive methylation of DiI-labeled LDL, which abolishes the ability of the cell to bind to the LDL receptor, prevented the internalization of the cholesterol moiety of LDL. Cellular binding of ~25I-LDL to U-25 I MG cells at 4~ revealed the presence of a specific saturable-associated receptor (dissociation constant (Kd) approximately 38 ~g/ml). Endocytic uptake of ~25I-LDL or 3H-cholesterol oleate-labeled LDL (3H-LDL) at 37~ demonstrated the cell-associated t25I-LDL and 3H-LDL increase. The intraceUular degradation of protein moiety increased linearly with time. Reductive methylation of aH-LDL led to a remarkable decrease in the cell-associated cholesterol moiety of LDL. The difference in uptake of the cholesterol moiety of LDL between U-25 IMG cells and KMG-5 cells showed that the U-25 IMG cells, which proliferate more actively than KMG-5 cells, take up more of the cholesterol moiety of LDL than do the KMG-5 cells.
L

OW-DENSITY lipoprotein (LDL) is an endogenous
carrier of cholesterol found in human plasma; 75% of the cholesterol in plasma is transported in LDL? Cells requiting cholesterol for membrane synthesis are known to take up LDL via receptor-mediated endocytosis or to initiate the de novo synthesis of cholesterol. The LDL-receptor activity is enhanced in rapidly proliferating cells in culture, whereas few receptors are found on nondividing cellsJ '~9 Such being the case, malignant tissue might be expected to have higher LDL-receptor activity than normal tissue with a very low rate of replication.~~ Epidemiological studies have shown an increased risk of death from cancer in subjects with low plasma cholesterol levels, unrelated to nutritional status. 6'8 '22 In cases of acute leukemia, leukemic blood and bonemarrow cells from most patients have elevated LDLreceptor activities compared with white blood cells and bone-marrow cells from healthy subjects. A high receptor-mediated uptake and degradation of LDL by the leukemic cells were shown to be the cause of hypocholesterolemia in cases of acute leukemia; 14' 33 hypocholesterolemia is a secondary phenomenon, due to the elevated LDL-receptor activity. Evidence for a high LDLreceptor activity in various tumor cells has also been obtained, both in vitro and in vivo. ~ t,~6, 26, 32 Recently, LDL-receptor activity has also been identified in normal tissues and neoplasms of the central nervous system. Pitas, et al..27 noted that rat astrocytes have the LDL receptor, and Rudling, et al., 3~ showed that a human malignant glioma cell line (U-251MG) accumulates and degrades LDL by a saturable highaffinity process. It has been shown by morphological techniques that neuronal growth cones of pheochromocytoma rapidly take up LDL via LDL receptor-mediated endocytosis. J7 In addition, it was also reported that after a crush injury to the rat sciatic nerve, a cholesterol transfer mechanism was required for rapid membrane biogenesis during axon regeneration and remyelination. 3 Thus, the role of LDL receptor in cholesterol Lipoprotein cholesterol uptake by gliomas transport in neural tissues has been the focus of particular attention.
In the present study, the interactions of LDL with human malignant glioma cell lines (U-251MG and KMG-5) were investigated biochemically and morphologically. Emphasis was placed on the dependency on LDL for the transfer of cholesterol into the human glioma cells.
Materials and Methods
Lipoprotein Isolation and Modification
Low-density lipoprotein (density (D) = 1.019 to 1.063) and lipoprotein-deficient serum (D > 1.25) were isolated by ultracentrifugation from fresh human plasma of normolipidemic subjects, after an overnight fast, as described. 25 The LDL was iodinated with the Bolton-Hunter reagent,* according to the manufacturer's instructions, to a specific activity of 270 cpm/ng of protein (~25I-LDL); other LDL was labeled with (3H)-cholesterol oleate, as described elsewhere 23 to a specific activity of 43 dpm/ng of total cholesterol ester (3H-LDL). In addition, LDL was labeled with fluorescein isothiocyanate (FITC) or with 1,1 '-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine (DiI), as follows. In brief, LDL concentrations of 4 to 5 mg/ml of protein were adjusted to a pH of 9 with bicarbonate buffer, and FITC solution, 5 mg/ml, was added at the ratio of 100 to 150 ug FITC/mg of LDL protein. The mixture was allowed to stand at room temperature for 4 hours, after which it was applied to a G-50 column equilibrated with a Tris-saline solution (pH 8.0) to remove the unbound fraction. The first eluting portion was collected and dialyzed against 0.15 M-NaC1, 0.02% ethylenediaminetetra-acetic acid (pH 7.4) (Buffer A). The molar ratio of FITC/LDL was about 2.3; FITC is covalently linked to the lysine residues of proteins. Therefore, the FITC-LDL indicated behavior of the protein moiety of LDL. Next, LDL (2 mg/ml) was mixed with lipoprotein-deficient serum (D > 1.25) and then DiI (3 mg/ml) in dimethyl sulfoxide was added. The mixture was allowed to stand at 37~ for 12 hours, after which it was ultracentrifuged for 24 hours at a density of 1.063 gm/ml to remove the unbound fraction. After centrifugation, the isolated fraction was dialyzed against Buffer A. Because DiI is a highly lipophilic molecule that can be noncovalently incorporated into LDL, the DiI-LDL indicated behavior of the cholesterol moiety of LDL. This procedure was based on previously reported methods. 9 '29 Reductive Methylation of 3H-LDL or DiI-LDL Tritiated LDL or DiI-LDL (3 to 5 mg/ml of protein), dissolved in Buffer A, was diluted with 0.3 M sodium borate buffer (pH 9.0) to 1.5 times the original volume.
* Bolton-Hunter reagent (2200 Ci/mmol) obtained from New England Nuclear, Boston, Massachusetts.
Reductive melhylation of 5 mg of the samples was performed at 0~ by adding 1 mg of sodium borohydrate (zero tirr.e for reaction sequence) followed by six additions over 30 minutes of 1 ul of 37% aqueous formaldehyde. After the last addition of formaldehyde, the reaction mixture was dialyzed at 4~ against Buffer A for 20 hour,s. The specific activity of reductive methylated 3H-LDL was 48 dpm/ng of total cholesterol ester. This procedure was based on previously reported methods. 34 
Binding Assay
For the binding assay, 105 U-251MG or KMG-5 malignant glioma cells? were plated in Medium A (Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum) into 24-well (16 • 16 mm) polystyrene dishes on Day 0. On Day 2, the medium wa~,; removed, and the cells were washed three times with l~hosphate-buffered saline (PBS). The medium was then replaced with 500 #1 of fresh Medium B (DMEM supplemented with 1% human serum albumin) with an indicated or fixed concentration of ~2~I-LDL, in the absence or presence of excess amounts of unlabeled LDL. After 3 hours of incubation at 4"C, the cells were washed three times with PBS, and 300 ul of 0.1 N NaC1 was added directly to the washed cells to determine the cellular binding of ~25I-LDL and cell protein concentration.
Endocytic Uptake of Radiolabeled LDL
Fixed a~nounts of ~25I-LDL were incubated with the cells in 500 ul of Medium B at 37"C and, at various times, cellular binding and intracellular degradation were determined as described. ~5' 24 The cells were also incubated with fixed amounts of 3H-LDL and reductive methylated 3H-LDL over time, or with indicated concentrations for 3 hours at 37~ After extensive washing of the cells, 300 ul of 0.1 N NaC1 was added for determination of cellular uptake and cell protein concentration, as described elsewhere. 23 
Morphological Behavior of LDL
The U-251MG glioma cells in Medium A were plated in an eight-well chamber, and on Day 2 the medium was replaced with Medium B. These cells were then incubated with 50 ug/ml of FITC-LDL and 15 tsg/ml of DiI-LDL in the absence or presence of excess amounls of unlabeled LDL for studies of protein moiety and the cholesterol moiety of LDL. After 30 minutes to 6 hoars of incubation at 37~ the cells were washed three times for 1 minute with PBS supplemented with 1% bovine serum albumin, then fixed with 4% paraformaldehyde for 1 hour at room temperature. Other U-251MG glioma cells were incubated with 15 ug/ml of t The U-251MG cell line was kindly provided by Dr. J Yoshida, Department of Neurosurgery, Nagoya University Medical School, Nagoya, Japan; the KMG-5 cell line was established in our laboratories. 2~ Lipoprotein cholesterol uptake by gliomas reductively methylated DiI-LDL for 6 hours. All of the cells were examined using fluorescence microscopy.
LDL-Receptor Localization
To study LDL-receptor localization, U-251MG cells were preincubated with Medium B overnight then fixed with 4% paraformaldehyde for 20 minutes at room temperature. They were then incubated at 1:50 with monoclonal anti-bovine LDL-receptor antibody (clone 7, which reacts with samples of human origin ~) as primary antibody for 1 hour at room temperature, and extensively washed in PBS. These cells were then incubated with FITC-labeled anti-mouse immunoglobulin G antibody for 40 minutes at room temperature. Fluorescence microscopy was used to examine LDL-receptor localization. Figure 1 shows the binding of 125I-LDL to U-251MG cells at 4"C, as a function of concentration. The binding was inhibited by more than 60% by an excess of unlabeled LDL. The specific binding, exhibiting a typical saturation curve, indicated the presence of a receptor specific for LDL on the plasma membranes of U-251MG cells. Scatchard analysis of this binding process gave a straight line, thereby suggesting a single mode of binding with an apparent dissociation constant (Kd) of approximately 38 ug/ml (1.7 • 10 -8 M) and maximum
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binding (Bmax) of 3.4 ug protein of LDL/mg cell protein.
Endocytic Uptake of LDL in U-251MG Cells
Endocytic uptake, an event occurring subsequent to the initial binding, was examined by incubating 125I-LDL at 37~ with U-251MG cells. As shown in Fig. 2 , the cell-associated 125I-LDL increased with time and reached equilibrium within 6 hours. The intracellular degradation of the ligand, as determined by an increase in trichloroacetic acid-soluble radioactivity in the medium, began at around 20 minutes after adding the radiolabeled ligand and continued to increase linearly with time thereafter.
To further determine behavior of the cholesterol moiety of LDL, the U-251MG cells were incubated at 37~ as a function of concentration, or with a fixed concentration of 3H-cholesterol oleate-labeled LDL, followed by determination of the cell-associated radioactivity. Consequently, the amounts of the cell-associated cholesterol moiety of LDL increased as a function of concentration (Fig. 3) or with time (data not shown). The reductive methylation of LDL, which abolishes its ability to bind to the LDL receptor, resulted in a remarkable decrease in the cell association of the cholesterol moiety of LDL in the cells as a function of concentration (Fig. 3) . These findings indicated that the uptake of cholesterol moiety of LDL was mediated via the LDL receptor present on the plasma membranes of the cells. 
FIG. 4. Labeling of U-251MG cells with FITC-labeled low-density lipoprotein (LDL)
.
Localization of FITC-LDL or DiI-LDL in U-251MG Cells
To determine behavior of the protein moiety and cholesterol moiety of LDL in U-251MG cells morphologically, FITC-LDL and DiI-LDL were used. An intense granular fluorescence pattern was observed within the cell body and processes of U-251MG cells after 6 hours of incubation of the cells with FITC-LDL at 37~ (Fig. 4 left) . Fluorescence labeling could be blocked by incubating the cells with a 30-fold excess of unlabeled LDL along with FITC-LDL (Fig. 4 right) , thereby indicating that the FITC-LDL was internalized via the LDL receptor in the cells.
To further determine the behavior of the cholesterol moiety of LDL, DiI-LDL was incubated with U-251MG cells over time at 37~ Granular staining was seen in the body of the cells as well as in their processes after 30 minutes of incubation (Fig. 5A ). An intense granular fluorescence pattern was observed within the body of the cells as well as their processes after 6 hours Lipoprotein cholesterol uptake by gliomas of incubation (Fig. 5B) . Fluorescence labeling could be blocked by incubating the cells with a 30-fold excess of unlabeled LDL (Fig. 5C) . Furthermore, reductive methylation of the apoprotein moiety of LDL, a procedure known to prevent receptor-mediated binding of LDL, prevented most of the binding and internalization of the DiI-LDL (Fig. 5D) .
Thus, the uptake of cholesterol moiety of LDL was mediated via the LDL receptor present on the plasma membrane of U-251MG cells.
LDL.Receptor Visualization in U-251MG Cells
Indirect immunofluorescence studies using the monoclonal anti-LDL-receptor antibody showed that the LDL-:eceptor was visible within the cell body and on the surface of the cells (Fig. 6) . In addition, a strongly positive immunoreaction was observed, especially in the dividing neoplastic cells.
Uptake of L D L Cholesterol in U-251MG and in K34G..5 Cells
To observe differences in the uptake of LDL cholesterol in the U-251MG and KMG-5 cells (the doubling time of which is approximately 25 and 100 hours, respeclively), endocytic uptake of LDL cholesterol was examined by biochemical techniques (Fig. 7) . Two kinds of cells were incubated at 37~ with 3H-LDL over time, followed by determination of the cell-associated cholesterol moiety of LDL. Uptake of the cholesterol moiety of LDL in the U-251MG cells was over threefold higher than in the KMG-5 cells, after incubation.
Discussion
The results of this study gave evidence that the LDL recepto:: is present on the plasma membranes of malignant glioma cells (U-251MG), and that the cholesterol moiety of LDL is endocytosed predominantly via the LDL receptor in the cells. The literature on LDL metabolism in tumors of the central nervous system is sparse. ~'~~ Rudling, et al., 3~ found that a human malignant glioma cell line (U-251MG) accumulates and degrades the apoprotein moiety of LDL by a saturable high-affinity process; however, little is known of the cholesterol metabolism of LDL in human glial neoplasms. Hence, we focused our study on the cholesterol metabolism of LDL in human malignant gtioma cell lines. It is well known that regulation of cellular cholesterol metabolism depends on sequential cell-surface binding, internalization, and intracellular degradation of LDL. ~2.~3
LDL Binding in Glioma
The cell-surface binding of ~2~I-LDL was studied at 4~ as sl:Lown in Fig. 1 . The data provide evidence that the plasma membranes of a human malignant glioma cell line (U-251MG) possess the high-affinity LDL receptor (Kd approximately 38 ug/ml). This is in good agreement with the study of Rudling, eta/.; 3~ the temperature at which the experiments were conducted could probably produce the different values of Kd of the LDL receptor in U-251MG cells seen between their data and ours.
Evidence that the LDL receptor was visualized within the cell bcdy as well as on the surface of the cells (Fig.  6 ) is interpreted to mean that the internalization of the LDL receptor into the cells occurs after binding to LDL, and/or that the binding of LDL receptor to the cell surface occurs following production of the LDL receptor in the Golgi apparatus. 2~
LDL Cholesterol Uptake in Glioma
It is of interest to know the extent to which transport of the cholesterol moiety of LDL into the human malignant glioma cells depends on the LDL receptor. For elucidation, lysine residues of LDL were modified by reductive methylation, a procedure known to block the interaction of LDL with the LDL receptor. 34 Modification of lysine residues by reductive methylation was shown to be an important procedure to probe the role of lysine in the recognition site since, unlike other modifications such as diketone and carbamoylation, this reaction did not alter the charge of the lysine or the net charge of LDL and yet was effective in blocking the binding activity of LDL. The lipid compositions were essentially identical for untreated LDL and for LDL modified by reductive methylation (data not shown). 34 In addition, DiI-lipoproteins were shown to have the same chemical composition and physical properties as the native lipoproteins. 28 ' 29 Consequently, biochemical and morphological evidence using reductively methylated LDL demonstrated that the amount of transport of cholesterol moiety of modified LDL into malignant glioma cells significantly decreased. Thus, it seems likely that more than 80% of the cholesterol moiety of LDL is endocytosed via the LDL receptor (Fig. 3) .
In vivo experiments revealed that about 80% of plasma LDL is cleared by the LDL receptor, and the 
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remaining 20% is removed by nonspecific mechanisms, determined using glucosylated LDL) 8 In addition, in vitro experiments raised the possibility of dual mechanisms for the uptake and regulation of LDL; in fibroblasts, almost all the LDL was endocytosed and degraded by a receptor-mediated mechanism while, in hepatocytes, even LDL modified by acetoacetylation, acetylation, and reductive methylation was endocytosed and degraded at 30% to 50% of the level of native LDL. 7 Therefore, the mechanism for the uptake and regulation of LDL in glioma cells seems to be similar to that in fibroblasts.
Implications of LDL Cholesterol Uptake in Glioma
It is also of interest to know the implications of uptake of cholesterol moiety of LDL in malignant glioma cells. For this study, we used other malignant glioma cells (the KMG-5 cell line 2~) which are known to divide less rapidly than U-251MG cells in culture systems. The doubling time of KMG-5 and U-251MG cells is 100 and 25 hours, respectively. 2' 2~ The binding of 125I-LDL to KMG-5 at 4"C was also inhibited in a dose-related manner by unlabeled LDL; however, the rate of inhibition was higher in the U-251MG than in the KMG-5 cells, suggesting that LDL-receptor activity might be higher in U-251MG than in KMG-5 cells (Fig.  8) . As shown in Fig. 7 , uptake of the cholesterol moiety of LDL in the U-251MG cells was three times than in the KMG-5 cells.
Thus, malignant glioma cells that grow more rapidly and have a higher activity of LDL receptor might need a larger amount of the cholesterol moiety of LDL. The cholesterol moiety of LDL is rapidly endocytosed in growth cones of pheochromocytoma cells, 17 and the rate of LDL uptake in cervical cancer cells ~ or leukemia cells 33 is much greater than that in corresponding non-neoplastic cells. In addition, it is shown that the extracytoplasmic domain of the LDL receptor contains a region that is 38% identical with a 96 amino acid sequence in the precursor to the epidermal growth factor?' Thus, large amounts of receptor-mediated uptake of the cholesterol moiety of LDL in malignant glioma cells may correlate with cell growth.
